# Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children

> **NCT04931641** · NA · COMPLETED · sponsor: **Swiss Federal Institute of Technology** · enrollment: 86 (actual)

## Conditions studied

- Iron Deficiency
- HIV

## Interventions

- **DIETARY_SUPPLEMENT:** Galacto-oligosaccharides
- **OTHER:** Maltodextrin
- **DIETARY_SUPPLEMENT:** Ferrous fumarate

## Key facts

- **NCT ID:** NCT04931641
- **Lead sponsor:** Swiss Federal Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-10-04
- **Final completion:** 2022-10-04
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931641, "Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04931641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*